Christopher J. Graber

2.9k total citations
66 papers, 2.0k citations indexed

About

Christopher J. Graber is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Christopher J. Graber has authored 66 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 25 papers in Infectious Diseases and 21 papers in Applied Microbiology and Biotechnology. Recurrent topics in Christopher J. Graber's work include Antibiotic Use and Resistance (21 papers), Bacterial Identification and Susceptibility Testing (16 papers) and Urinary Tract Infections Management (13 papers). Christopher J. Graber is often cited by papers focused on Antibiotic Use and Resistance (21 papers), Bacterial Identification and Susceptibility Testing (16 papers) and Urinary Tract Infections Management (13 papers). Christopher J. Graber collaborates with scholars based in United States, Qatar and United Kingdom. Christopher J. Graber's co-authors include Henry F. Chambers, Françoise Perdreau‐Remington, Huong Minh Nguyen, Binh An Diep, Matthew Bidwell Goetz, George F. Sensabaugh, Li Basuino, Glen Huang, Alison C. Jones and Heather A. Carleton and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Christopher J. Graber

63 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher J. Graber United States 21 1.2k 613 494 417 352 66 2.0k
Isaac See United States 24 1.0k 0.9× 432 0.7× 379 0.8× 712 1.7× 371 1.1× 53 2.3k
Robin Howe United Kingdom 27 966 0.8× 603 1.0× 645 1.3× 606 1.5× 227 0.6× 56 2.3k
James A. McKinnell United States 27 1.3k 1.1× 480 0.8× 349 0.7× 806 1.9× 243 0.7× 81 2.5k
Kyle J. Popovich United States 25 1.3k 1.1× 609 1.0× 261 0.5× 461 1.1× 303 0.9× 56 1.7k
Kathryn Como‐Sabetti United States 16 1.3k 1.1× 702 1.1× 384 0.8× 482 1.2× 740 2.1× 34 1.9k
Samantha J. Eells United States 25 1.1k 1.0× 633 1.0× 344 0.7× 425 1.0× 511 1.5× 40 1.7k
Mark D. King United States 13 1.6k 1.3× 916 1.5× 557 1.1× 539 1.3× 590 1.7× 18 2.2k
Donna M. Hacek United States 24 1.4k 1.2× 644 1.1× 189 0.4× 589 1.4× 203 0.6× 37 2.1k
G. Duckworth United Kingdom 26 1.7k 1.5× 710 1.2× 346 0.7× 711 1.7× 549 1.6× 49 2.8k
Rosy Reynolds United Kingdom 24 611 0.5× 471 0.8× 279 0.6× 609 1.5× 202 0.6× 62 2.1k

Countries citing papers authored by Christopher J. Graber

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Graber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Graber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Graber more than expected).

Fields of papers citing papers by Christopher J. Graber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Graber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Graber. The network helps show where Christopher J. Graber may publish in the future.

Co-authorship network of co-authors of Christopher J. Graber

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Graber. A scholar is included among the top collaborators of Christopher J. Graber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Graber. Christopher J. Graber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Livorsi, Daniel J., Westyn Branch‐Elliman, Dimitri Drekonja, et al.. (2024). Research agenda for antibiotic stewardship within the Veterans’ Health Administration, 2024–2028. Infection Control and Hospital Epidemiology. 45(8). 923–929. 4 indexed citations
2.
Goetz, Matthew Bidwell, Tina M. Willson, Michael Rubin, Vanessa Stevens, & Christopher J. Graber. (2024). Antimicrobial use before and during COVID-19: data from 108 Veterans Affairs medical centers. SHILAP Revista de lepidopterología. 4(1). e109–e109.
3.
Graber, Christopher J., Yue Zhang, Matthew Bidwell Goetz, et al.. (2022). Performance of infectious diseases specialists, hospitalists, and other internal medicine physicians in antimicrobial case-based scenarios: Potential impact of antimicrobial stewardship programs at 16 Veterans’ Affairs medical centers. Infection Control and Hospital Epidemiology. 44(3). 400–405. 1 indexed citations
4.
5.
Furukawa, Daisuke, Christopher J. Graber, Vanessa Stevens, et al.. (2020). Inpatient antibiotic utilization in the Veterans’ Health Administration during the coronavirus disease 2019 (COVID-19) pandemic. Infection Control and Hospital Epidemiology. 42(6). 751–753. 26 indexed citations
6.
Trautner, Barbara W., Yiqun Wang, John Van, et al.. (2020). Organizational readiness assessment in acute and long-term care has important implications for antibiotic stewardship for asymptomatic bacteriuria. American Journal of Infection Control. 48(11). 1322–1328. 6 indexed citations
7.
Howard‐Anderson, Jessica, et al.. (2019). Internal medicine residents’ evaluation of fevers overnight. Diagnosis. 6(2). 157–163. 5 indexed citations
8.
Drekonja, Dimitri, Larissa Grigoryan, Paola Lichtenberger, et al.. (2019). Teamwork and safety climate affect antimicrobial stewardship for asymptomatic bacteriuria. Infection Control and Hospital Epidemiology. 40(9). 963–967. 15 indexed citations
9.
Trautner, Barbara W., Pooja Prasad, Larissa Grigoryan, et al.. (2018). Protocol to disseminate a hospital-site controlled intervention using audit and feedback to implement guidelines concerning inappropriate treatment of asymptomatic bacteriuria. Implementation Science. 13(1). 16–16. 34 indexed citations
10.
Watson, Richard L. & Christopher J. Graber. (2018). Lack of improvement in antimicrobial prescribing after a diagnosis of Clostridium difficile and impact on recurrence. American Journal of Infection Control. 46(12). 1370–1374. 2 indexed citations
11.
12.
Graber, Christopher J., et al.. (2013). Cephalothin susceptibility testing as class representative for oral cephalosporins: is it time to move on?. Diagnostic Microbiology and Infectious Disease. 76(4). 483–485. 7 indexed citations
13.
Tattevin, Pierre, Brian S. Schwartz, Christopher J. Graber, et al.. (2012). Concurrent Epidemics of Skin and Soft Tissue Infection and Bloodstream Infection Due to Community-Associated Methicillin-Resistant Staphylococcus aureus. Clinical Infectious Diseases. 55(6). 781–788. 59 indexed citations
14.
Nicolau, David P., Yehuda Carmeli, Christopher W. Crank, et al.. (2011). Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence. International Journal of Antimicrobial Agents. 39(1). 11–15. 52 indexed citations
15.
16.
Graber, Christopher J., Andi L. Shane, Peggy Sue Weintrub, & Henry F. Chambers. (2011). Clonality of Staphylococcus aureus Colonization over Time in Attendees of a Camp for Children with Chronic Dermatoses. Pediatric Dermatology. 28(5). 519–523. 10 indexed citations
17.
Liu, Catherine, Christopher J. Graber, Binh An Diep, et al.. (2008). A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐ResistantStaphylococcus aureusDisease in San Francisco, 2004–2005. Clinical Infectious Diseases. 46(11). 1637–1646. 168 indexed citations
18.
Diep, Binh An, Henry F. Chambers, Christopher J. Graber, et al.. (2008). Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with Men. Annals of Internal Medicine. 148(4). 249–257. 312 indexed citations
19.
Graber, Christopher J., Adam S. Lauring, & Peter Chin‐Hong. (2007). A Stitch in Time. New England Journal of Medicine. 357(10). 1029–1034. 1 indexed citations
20.
Fahle, Gary A., et al.. (2001). Comparison of a quantitative Real-Time PCR assay with pp65 antigenemia and NucliSens pp67 mRNA for detection of cytomegalovirus viremia in bone marrow transplant patients. 101. 180. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isaac See Breakdown of academic impact, for papers by Robin Howe Breakdown of academic impact, for papers by James A. McKinnell Breakdown of academic impact, for papers by Kyle J. Popovich Breakdown of academic impact, for papers by Kathryn Como‐Sabetti Breakdown of academic impact, for papers by Samantha J. Eells Breakdown of academic impact, for papers by Mark D. King Breakdown of academic impact, for papers by Donna M. Hacek Breakdown of academic impact, for papers by G. Duckworth Breakdown of academic impact, for papers by Rosy Reynolds
Rankless by CCL
2026